Short answer
Humana (HUM) filed its Q2 2025 10-Q quarterly report on Jul 30, 2025 for the quarter ended Jun 30, 2025. Quarterly revenue was $32.4B (up 9.6% year over year) with net income of $545M.
Q2 2025 key financials · XBRL
- Revenue
- $32.4B
- +9.6% YoY · +0.9% QoQ
- Net income
- $545M
- −19.7% YoY · −56.2% QoQ
- Operating margin
- 3.4%
- EPS (diluted)
- $4.51
- −19.9% YoY · −56.2% QoQ
Source: XBRL data from the Humana (HUM) Q2 2025 10-Q on SEC EDGAR. USD.
Humana Q2 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New risk: Additional impairment charges of $32M for indefinite-lived intangible assets in H1 2025, none recorded in same period 2024, triggered by value creation initiatives
- Most material update: Shift in Medicare Part D benefit design due to Inflation Reduction Act of 2022 causing more level prescription costs and increased plan liabilities risk
- Regulatory risk: Potential regulatory restrictions on Medicare Advantage profitability comparisons, premium growth, provider network management, and Part D benefit design changes could adversely impact operations
- Operational/market risk: 6.9% decline in individual Medicare Advantage membership due to exiting unprofitable plans and counties impacting near-term revenue mix and growth
- Financial risk: Issuance of $2B senior notes in March 2025 to repay $577M maturing debt with increased cash to $4.0B by June 30, 2025 supporting liquidity and debt refinancing plans
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Humana quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.